ETFs

Lazydays (GORV) Expected to Announce Earnings on Friday

Lazydays (NASDAQ:GORV – Get Free Report) is anticipated to announce its earnings...

BMO Capital Markets Forecasts Strong Price Appreciation...

Okta (NASDAQ:OKTA – Get Free Report) had its price objective boosted by investme...

O’Reilly Automotive (NASDAQ:ORLY) Earns “Buy” Rating fr...

O’Reilly Automotive (NASDAQ:ORLY – Get Free Report)‘s stock had its “buy” rating...

RAPT Therapeutics’ (RAPT) Buy Rating Reaffirmed at HC W...

RAPT Therapeutics (NASDAQ:RAPT – Get Free Report)‘s stock had its “buy” rating r...

Barclays Issues Pessimistic Forecast for Old Dominion F...

Old Dominion Freight Line (NASDAQ:ODFL – Get Free Report) had its price objectiv...

ProQR Therapeutics (NASDAQ:PRQR) Stock Rating Upgraded ...

ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) was upgraded by investment an...

Methanex (NASDAQ:MEOH) Cut to “Sector Perform” at Scoti...

Methanex (NASDAQ:MEOH – Get Free Report) (TSE:MX) was downgraded by analysts at ...

Orchestra BioMed’s (OBIO) “Buy” Rating Reiterated at HC...

Orchestra BioMed (NASDAQ:OBIO – Get Free Report)‘s stock had its “buy” rating re...

Immunome’s (IMNM) “Outperform” Rating Reaffirmed at Wed...

Immunome (NASDAQ:IMNM – Get Free Report)‘s stock had its “outperform” rating rei...

Bank of America Has Lowered Expectations for Merus (NAS...

Merus (NASDAQ:MRUS – Get Free Report) had its target price lowered by analysts a...

Benchmark Reaffirms Buy Rating for Magnite (NASDAQ:MGNI)

Magnite (NASDAQ:MGNI – Get Free Report)‘s stock had its “buy” rating reaffirmed ...

Guggenheim Cuts iHeartMedia (NASDAQ:IHRT) Price Target ...

iHeartMedia (NASDAQ:IHRT – Get Free Report) had its price target reduced by equi...

Wedbush Reaffirms Outperform Rating for Inozyme Pharma ...

Inozyme Pharma (NASDAQ:INZY – Get Free Report)‘s stock had its “outperform” rati...

Pulmonx (NASDAQ:LUNG) Now Covered by Analysts at D. Bor...

Investment analysts at D. Boral Capital initiated coverage on shares of Pulmonx ...

4D Molecular Therapeutics (NASDAQ:FDMT) Given New $40.0...

4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report) had its price target d...

Hoth Therapeutics (NASDAQ:HOTH) Given “Buy” Rating at D...

Hoth Therapeutics (NASDAQ:HOTH – Get Free Report)‘s stock had its “buy” rating r...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.